DUBLIN, October 4, 2017 /PRNewswire/ --
The "Global Peripheral Vascular Stents Market 2017-2021" report has been added to Research and Markets' offering.
The global peripheral vascular stents market to grow at a CAGR of 7.96% during the period 2017-2021.
Global Peripheral Vascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is Technology caters the pace for advances in stenting. Peripheral vascular stents play a key role in the treatment of PADs and restenosis. In the last decade, there has been a continuous focus on technological advances in terms of design and materials to prevent the narrowing of a blood vessel and to improve long-term effectivity.
According to the report, one of the major drivers for this market is Ubiquity of PAD. The global prevalence of PAD increased by a significant percentage in the last decade. Approximately one-fourth of the world's population has PAD, and the number is increasing in developing economies. The growing prevalence of PAD is the primary factor involved in the higher sales of peripheral vascular stents. The prevalence of PAD among the developed nations is as similar as the developing nations.
Further, the report states that one of the major factors hindering the growth of this market is Risks and complications associated with peripheral vascular stents. Although angioplasty and vascular stenting are the standard procedures to be followed, there are some risks and complications associated with the peripheral vascular stents. The primary complications associated with the usage of peripheral stents are the reoccurrence of stenosis and thrombosis. The procedure consists of minor and major complications associated with stentings, such as perforation, stent migration, fever, intra-procedural complications, and in few cases, allergic reactions to medication or dye.
- Boston Scientific
- C. R. Bard
- Cordis (a Cardinal Health company)
Other prominent vendors
- 480 Biomedical
- B. Braun Melsungen
- Biosensors International Group
- InSitu Technologies
- KYOTO MEDICAL PLANNING
- Meril Life Sciences
- PanMed US
- Terumo Medical
- Veryan Medical
- W. L. Gore & Associates
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market Landscape
Part 06: Five Forces Analysis
Part 07: Market Segmentation By Product
Part 08: Market Segmentation By End-User
Part 09: Geographical Segmentation
Part 10: Decision Framework
Part 11: Drivers And Challenges
Part 12: Market Trends
Part 13: Vendor Landscape
Part 14: Key Vendor Analysis
Part 15: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/gxc8ch/global_peripheral
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets